A brain pacemaker that can actually hear and respond to your brain’s signals may sound like science fiction, but for people with Parkinson’s disease, this technology is now reality. The FDA approved Medtronic’s BrainSense™ adaptive deep brain stimulation (aDBS) system in February 2025, marking a significant advancement from traditional “always-on” systems to personalized, responsive therapy. For the estimated 10 million people worldwide living with Parkinson’s, this advancement could mean fewer side effects and better control of symptoms, especially walking difficulties that can lead to dangerous falls. Could Adaptive DBS Help Me? 1. Have you had Parkinson’s for at least 4 … Continue reading Adaptive DBS Cuts Energy Use by 40% as FDA Approves BrainSense™ for Parkinson’s